Icosapent ethyl: a review of its use in severe hypertriglyceridemia.

about

Icosapent ethyl: a review of its use in severe hypertriglyceridemia.

Item

http://www.wikidata.org/entity/Q38271868

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Icosapent ethyl: a review of its use in severe hypertriglyceridemia.

@en

type

Item

label

Icosapent ethyl: a review of its use in severe hypertriglyceridemia.

@en

prefLabel

Icosapent ethyl: a review of its use in severe hypertriglyceridemia.

@en

P1476

Icosapent ethyl: a review of its use in severe hypertriglyceridemia.

@en

P2093

Esther S Kim

http://www.w3.org/2001/XMLSchema#string

Paul L McCormack

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

Overview of prescription omega-3 fatty acid products for hypertriglyceridemia

Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.

Effect of icosapent ethyl (eicosapentaenoic acid ethyl ester) on omeprazole plasma pharmacokinetics in healthy adults.

Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial).

The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis.

Phase 1 study of the effect of icosapent ethyl on warfarin pharmacokinetic and anticoagulation parameters.

Effects of extended-release niacin with laropiprant in high-risk patients.

Pharmacokinetics of Eicosapentaenoic Acid in Plasma and Red Blood Cells After Multiple Oral Dosing With Icosapent Ethyl in Healthy Subjects.

P2888

s40256-014-0099-7

P304

471-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-014-0099-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268880328

http://www.w3.org/2001/XMLSchema#string

P6179

1003568366

http://www.w3.org/2001/XMLSchema#string

P698

25428605

http://www.w3.org/2001/XMLSchema#string

P921

icosapent ethyl